D-0379-2021 Class III Terminated
FDA drug recall D-0379-2021 was initiated by SigmaPharm Laboratories LLC on Apr 19, 2021 and is designated Class III. Reason for recall: Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent The recall status is terminated (terminated Sep 26, 2022). Affected quantity: 6266 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 26, 2021
- Initiation Date
- Apr 19, 2021
- Termination Date
- Sep 26, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6266 bottles
Product description
Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10.
Reason for recall
Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent
Distribution pattern
Nationwide in the US
Code information
Lots # 2012501, 2012601 , 2012701, & 2100701, Exp. AUG 2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0379-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026